MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-GJ-14-0001125
Noronic Pharmaceutical Private Limited - pharma in Kadi, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹46.65 Cr
▲ 65% YoY
Net profit · FY 2025
₹96.22 Lakh
Net margin 2.1%
EBITDA · FY 2025
₹2.67 Cr
EBITDA margin 5.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Open charges
₹1.1 Cr
Secured borrowings
Company age
10 yrs
Est. 2016
Employees · EPFO
8
Provident fund records
About Noronic Pharmaceutical Private Limited
Data last updated:
Noronic Pharmaceutical Private Limited is a private limited company based in Kadi, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 July 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24302GJ2016PTC092775. Its GSTIN is 24AAFCN3171R1Z1 (Gujarat).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Nikulkumar Bharatbhai Patel and Maulikkumar Rameshbhai Patel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at At – Indrad Ls – 763/2 Near Zedchem Ind Indrad, Kadi, Gujarat, India – 382715.
As per the financials filed for FY 2025, the company reported a revenue of ₹46.65 Cr, a growth of 65% compared to the previous year. For the same year it recorded a net profit of ₹96.22 Lakh (net margin 2.1%) and EBITDA of ₹2.67 Cr (EBITDA margin 5.7%). Revenue has grown at a compounded annual rate (CAGR) of 74% over three years and 34% over five years.
The company has about 8 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Noronic Pharma. As per MCA filings, the company has open charges of ₹1.1 Cr on record.
Noronic Pharmaceutical Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-GJ-14-0001125). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website noronicpharma.com.
Company details
CIN U24302GJ2016PTC092775
Registration Number 092775
Incorporation Date 04 July 2016
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-GJ-14-0001125
Recognitions & Rankings of Noronic Pharmaceutical
Contact details
Noronic Pharmaceutical Private Limited's registered office is in Kadi, Gujarat. Its website is noronicpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressAt – Indrad Ls – 763/2 Near Zedchem Ind Indrad, Kadi, Gujarat, India – 382715
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Noronic Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Noronic Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Noronic Pharmaceutical operates one associated brand: Noronic Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and exports high-quality pharmaceutical products. | noronicpharma.com |
Business activity
The main business activity of Noronic Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Noronic Pharmaceutical Private Limited, buy the company report.
Financials of Noronic Pharmaceutical Private Limited
FY 2025 filings availableNoronic Pharmaceutical Private Limited reported revenue of ₹46.65 Cr (up 65% YoY) for FY 2025.
Revenue · FY 2025
₹46.65 Cr ▲ 65%
Net profit · FY 2025
₹96.22 Lakh margin 2.1%
EBITDA · FY 2025
₹2.67 Cr margin 5.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 65%
3 years · compounded
▲ 74%
5 years · compounded
▲ 34%
EBITDA CAGR growth
1 year
▲ 67%
5 years · compounded
▲ 64%
Revenue has grown at a compounded annual rate (CAGR) of 34% over five years, including 65% growth in the latest year. EBITDA rose 67% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.67 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹96.22 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.7% | ||||
| Net Profit Margin | 2.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Noronic Pharmaceutical Private Limited, buy the company report.
Board of directors of Noronic Pharmaceutical Private Limited
Noronic Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nikulkumar Bharatbhai Patel | Director | 04 Jul 2016 | 10 Years 3 Months | Current |
| Maulikkumar Rameshbhai Patel Also directs: Neza Pharmaceuticals Private Limited | Director | 05 Apr 2021 | 5 Years 6 Months | Current |
Peer comparison
Noronic Pharmaceutical Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Noronic Pharmaceutical Private Limitedthis company | ₹46.65 Cr (FY 2025) | ₹96.22 Lakh | 2.1% | 65.0% | 8 | Kadi, Gujarat, India |
| Medizest Pharmaceuticals Private Limited | ₹20.59 Cr (FY 2024) | 54.0% | Verna, Goa, India | |||
| Morvin India Health Care Private Limited | ₹20.53 Cr (FY 2025) | 14.0% | Sanand, Gujarat, India | |||
| Neomediispecs Private Limited | ₹20.5 Cr (FY 2025) | -24.0% | Chennai, Tamil Nadu, India | |||
| Apollo Ingredients India Private Limited | ₹20.45 Cr (FY 2024) | -30.0% | Thane, Maharashtra, India | |||
| Ukay Remedys Private Limited | ₹20.31 Cr (FY 2024) | 29.0% | Vasai, Maharashtra, India | |||
| Ariston Pharma Nova Tech Private Limited | ₹20.3 Cr (FY 2019) | -47.0% | Hyderabad, Telangana, India | |||
| Janya Biocare Private Limited | ₹20.29 Cr (FY 2025) | -19.0% | Roorkee, Uttarakhand, India |
To see the full peer comparison of Noronic Pharmaceutical Private Limited, buy the company report.
Auditor
Noronic Pharmaceutical Private Limited is audited by KHP & ASSOCIATES. for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KHP & ASSOCIATES. | FY 2022 | 134107W |
Shareholding
The shareholding of Noronic Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Noronic Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.1 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 May 2017 | 100095432 | Others | ₹1.1 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Noronic Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Noronic Pharmaceutical Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 34 overdue payments to 34 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 34)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Madhu Packaging | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Noronic Pharmaceutical Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Noronic Pharmaceutical Private Limited has a workforce of 8 employees on its EPFO records as of Oct 09, 2025, across 1 active EPFO establishment.
Employee count
8
Active EPFO establishments
1
Employee growth
14.29%
GST
Noronic Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAFCN3171R1Z1 | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Noronic Pharmaceutical Private Limited, buy the company report.
Recent activity
Noronic Pharmaceutical Private Limited has 4 board changes on record since 2016: 3 appointments and 1 cessation. The latest: Nidhiben Karshanbhai Patel ceased to be Director on 20 May 2021.
AGM
Noronic Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Noronic Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Ceased
Nidhiben Karshanbhai Patel ceased to be Director.
Appointed
Maulikkumar Rameshbhai Patel was appointed as Director.
Charges
A charge with Others amounted to Rs. 110.00 Lakh with Charge ID 100095432 was registered on 01 May 2017.
Appointed
Nidhiben Karshanbhai Patel was appointed as Director.
Appointed
Nikulkumar Bharatbhai Patel was appointed as Director.
Incorporation
04 Jul 2016
Noronic Pharmaceutical Private Limited was registered on 04 Jul 2016 with Roc Ahmedabad & aged 10 years 3 months as per MCA records.
Frequently asked questions
Noronic Pharmaceutical is an active private limited company based in Kadi, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 July 2016 (10+ years old) and is registered under CIN U24302GJ2016PTC092775.
Noronic Pharmaceutical has 2 current directors:
- Nikulkumar Bharatbhai Patel - Director
- Maulikkumar Rameshbhai Patel - Director
The latest financial statements of Noronic Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Noronic Pharmaceutical is 24AAFCN3171R1Z1, registered in Gujarat.
The CIN (Corporate Identification Number) of Noronic Pharmaceutical is U24302GJ2016PTC092775. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Noronic Pharmaceutical was incorporated on 04 July 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Noronic Pharmaceutical by revenue are Medizest Pharmaceuticals Private Limited, Morvin India Health Care Private Limited, Neomediispecs Private Limited, Apollo Ingredients India Private Limited, Ukay Remedys Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Nidhiben Karshanbhai Patel ceased to be Director on 20 May 2021. Maulikkumar Rameshbhai Patel was appointed as Director on 05 Apr 2021. Nidhiben Karshanbhai Patel was appointed as Director on 04 Jul 2016. Noronic Pharmaceutical has 4 board changes on record in total.
Yes, Noronic Pharmaceutical is registered as an MSME under Udyam registration (number: UDYAM-GJ-14-0001125).
Noronic Pharmaceutical has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 34 overdue payments to 34 micro and small suppliers. The latest return was filed on 31 May 2019.
Noronic Pharmaceutical can be reached through the website noronicpharma.com. Its registered office is in Kadi, Gujarat, India.
The registered office of Noronic Pharmaceutical is at At – Indrad Ls – 7632 Near Zedchem Ind Indrad, Kadi, Gujarat, India – 382715.